These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9661907)

  • 1. p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation.
    Casamassimi A; Miano MG; Porcellini A; De Vita G; de Nigris F; Zannini M; Di Lauro R; Russo T; Avvedimento VE; Fusco A
    Cancer Res; 1998 Jul; 58(13):2888-94. PubMed ID: 9661907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
    Moretti F; Farsetti A; Soddu S; Misiti S; Crescenzi M; Filetti S; Andreoli M; Sacchi A; Pontecorvi A
    Oncogene; 1997 Feb; 14(6):729-40. PubMed ID: 9038381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of activating mutations of GalphaS and the thyrotropin receptor on proliferation and differentiation of thyroid follicular cells.
    Ludgate M; Gire V; Crisp M; Ajjan R; Weetman A; Ivan M; Wynford-Thomas D
    Oncogene; 1999 Aug; 18(34):4798-807. PubMed ID: 10490813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutated p53 gene alters thyroid cell differentiation.
    Battista S; Martelli ML; Fedele M; Chiappetta G; Trapasso F; De Vita G; Battaglia C; Santoro M; Viglietto G; Fagin JA
    Oncogene; 1995 Nov; 11(10):2029-37. PubMed ID: 7478522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The v-erbA oncogene selectively inhibits iodide uptake in rat thyroid cells.
    Trapasso F; Martelli ML; Battaglia C; Angotti E; Mele E; Stella A; Samarut J; Avvedimento VE; Fusco A
    Oncogene; 1996 May; 12(9):1879-88. PubMed ID: 8649848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the cAMP pathway synergistically increases IL-1-induced IL-6 gene expression in FRTL-5 thyroid cells: involvement of AP-1 transcription factors.
    Szabo-Fresnais N; Blondeau JP; Pomérance M
    Mol Cell Endocrinol; 2008 Mar; 284(1-2):28-37. PubMed ID: 18280640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
    Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
    Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells.
    Portella G; Vitagliano D; Borselli C; Melillo RM; Salvatore D; Rothstein JL; Vecchio G; Fusco A; Santoro M
    Oncol Res; 1999; 11(9):421-7. PubMed ID: 10821536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells.
    Fournes B; Monier R; Michiels F; Milgrom E; Misrahi M; Feunteun J
    Oncogene; 1998 Feb; 16(8):985-90. PubMed ID: 9519872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line.
    Portella G; Vitagliano D; Li Z; Sferratore F; Santoro M; Vecchio G; Fusco A
    Oncol Res; 1998; 10(9):441-7. PubMed ID: 10223619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of c-ras reactivates thyroglobulin synthesis in middle-T transformed thyroid cells.
    Di Jeso B; Feliciello A; Pacifico F; Iannelli A; D'Armiento F; Liguoro D; Giuliano P; Ferulano G; Avvedimento EV
    Cell Growth Differ; 1995 Oct; 6(10):1315-9. PubMed ID: 8845309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
    Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
    Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc and p53 gene expression in the differentiation of temperature-sensitive mutants of teratocarcinoma F9 cells.
    Kosaka M; Iwai SA; Nishina Y; Sumi T; Nishimune Y
    Oncogene; 1992 Dec; 7(12):2455-60. PubMed ID: 1461650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3',5'-cyclic adenosine monophosphate-regulated enhancer binding (CREB) activity is required for normal growth and differentiated phenotype in the FRTL5 thyroid follicular cell line.
    Woloshin PI; Walton KM; Rehfuss RP; Goodman RH; Cone RD
    Mol Endocrinol; 1992 Oct; 6(10):1725-33. PubMed ID: 1333055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
    Barzon L; Gnatta E; Castagliuolo I; Trevisan M; Moretti F; Pontecorvi A; Boscaro M; Palù G
    Cancer Gene Ther; 2005 Apr; 12(4):381-8. PubMed ID: 15650765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mutationally activated G alpha s stimulates growth and differentiation of thyroid FRTL5 cells.
    Muca C; Vallar L
    Oncogene; 1994 Dec; 9(12):3647-53. PubMed ID: 7526317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation.
    Cass LA; Meinkoth JL
    Oncogene; 2000 Feb; 19(7):924-32. PubMed ID: 10702801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.